enGene Therapeutics
Develops non-viral genetic medicines led by a bladder-cancer therapy candidate.
$1.83
After-hours close+0.00 (+0.08%)
At close$1.83(−4.19%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 74.29%49.76M sharesInsiders 0.05%34.4K sharesOther 25.66%17.19M shares
Shares outstanding 66.99M · Float 24.51M · 36.6% free float
Institutions13F, as of Jun 30, 2026
66 holders · 49.76M shares · 22 new positions · 36 increased · 17 reduced · 21 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FCPM Iii Services B.V. | 9.63M | 14.38% | 0 | Aug 14, 2026 |
| BML Capital Management, LLC | 6.67M | 9.96% | +6.67Mnew | Aug 7, 2026 |
| Siren, L.L.C. | 6.26M | 9.34% | +6.26Mnew | Aug 13, 2026 |
| Perceptive Advisors LLC | 4.82M | 7.20% | +4.82Mnew | Aug 14, 2026 |
| Ameriprise Financial Inc | 2.68M | 3.99% | +2.68Mnew | Aug 14, 2026 |
| Nextech Invest, Ltd. | 2.32M | 3.47% | +2.32Mnew | Aug 14, 2026 |
| Adar1 Capital Management, LLC | 2.10M | 3.14% | +2.10Mnew | Aug 14, 2026 |
| Vestal Point Capital, LP | 1.67M | 2.49% | +1.67Mnew | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Perceptive Advisors LLC | 9.99% | 6.77M | 13G | Nov 18, 2025 ↗ |
| BML Investment Partners, L.P. | 9.95% | 6.67M | 13G | May 14, 2026 ↗ |
| Venrock Healthcare Capital Partners III, L.P. | 7.10% | 4.77M | 13G | Feb 17, 2026 ↗ |
| Invus Public Equities, L.P. | 6.70% | 4.51M | 13G | May 5, 2026 ↗ |
| Deep Track Capital, LP | 6.69% | 4.32M | 13G | Nov 18, 2025 ↗ |
| Phillip Grossincl. Robert Atchinson, Adage Capital Management, L.P. | 5.27% | 2.33M | 13G | Nov 12, 2024 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Philip Astley-Sparke | director | 20.0K | 0.03% | Jul 8, 2025 |
| Matthew Ross Boyd | officer: Chief Regulatory Officer | 7.5K | 0.01% | Jul 14, 2025 |
| Kathleen P. Richton | officer: SVP, Finance and Treasurer | 6.9K | 0.01% | Jul 22, 2026 |
6 ten-percent owners hold 11.91M shares by Form 4, outside the officers-and-directors figure above · 4 people have not refiled in the last 18 months (376.4K shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.